Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis (Q37928607)

25 August 2017

0 references

1 reference

title

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis (English)

1 reference

25 August 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Ping Wang

1

1 reference

25 August 2017

Donghong Kang

2

1 reference

25 August 2017

Wei Cao

3

1 reference

25 August 2017

Yan Wang

4

1 reference

25 August 2017

Zhiwen Liu

5

1 reference

25 August 2017

1 February 2012

1 reference

Diabetes - Metabolism: Research and Reviews

25 August 2017

1 reference

25 August 2017

28

1 reference

25 August 2017

109-122

1 reference

25 August 2017

2

1 reference

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

25 August 2017

1 reference

7 January 2021

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

7 January 2021

Hepatocellular carcinoma in the Asia pacific region

1 reference

7 January 2021

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

7 January 2021

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

1 reference

7 January 2021

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

7 January 2021

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.

1 reference

7 January 2021

Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence

1 reference

7 January 2021

Metabolic disturbances in non-alcoholic fatty liver disease.

1 reference

7 January 2021

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

7 January 2021

Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.

1 reference

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

7 January 2021

Attributable risks for hepatocellular carcinoma in Northern Italy

1 reference

7 January 2021

Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients

1 reference

7 January 2021

Fasting serum glucose level and cancer risk in Korean men and women

1 reference

7 January 2021

Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus

1 reference

7 January 2021

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

1 reference

7 January 2021

Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada

1 reference

7 January 2021

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

7 January 2021

Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

1 reference

7 January 2021

Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study.

1 reference

7 January 2021

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

7 January 2021

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

1 reference

7 January 2021

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

1 reference

7 January 2021

A case-control study on male hepatocellular carcinoma based on hospital and community controls.

1 reference

7 January 2021

Diabetes mellitus and the risk of primary liver cancer.

1 reference

7 January 2021

A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma

1 reference

7 January 2021

A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan

1 reference

7 January 2021

Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, California

1 reference

7 January 2021

Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies

1 reference

7 January 2021

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

1 reference

7 January 2021

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

1 reference

7 January 2021

Risk of cancer in a large cohort of U.S. veterans with diabetes.

1 reference

7 January 2021

Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications

1 reference

7 January 2021

Risk of cancer following hospitalization for type 2 diabetes

1 reference

7 January 2021

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.

1 reference

7 January 2021

Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients.

1 reference

7 January 2021

Diabetes, prediabetes and cancer mortality

1 reference

7 January 2021

Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis.

1 reference

7 January 2021

Excess risk of primary liver cancer in patients with diabetes mellitus

1 reference

7 January 2021

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

1 reference

7 January 2021

Prospective study of diabetes mellitus and liver cancer in Japan

1 reference

7 January 2021

Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.

1 reference

7 January 2021

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection

1 reference

7 January 2021

Mortality from site-specific malignancies in type 2 diabetic patients from Verona

1 reference

7 January 2021

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

7 January 2021

Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study

1 reference

7 January 2021

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

7 January 2021

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

7 January 2021

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan

1 reference

7 January 2021

Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection

1 reference

7 January 2021

Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis

1 reference

7 January 2021

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis

1 reference

7 January 2021

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

1 reference

7 January 2021

8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

1 reference

7 January 2021

Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis

1 reference

7 January 2021

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

1 reference

7 January 2021

Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.

1 reference

7 January 2021

Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus

1 reference

7 January 2021

A cohort study of the risk of cancer associated with type 2 diabetes

1 reference

7 January 2021

The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses

1 reference

7 January 2021

AMP-activated protein kinase as a drug target.

1 reference

7 January 2021

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

7 January 2021

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

7 January 2021

A prospective study of obesity and cancer risk (Sweden).

1 reference

7 January 2021

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

7 January 2021

Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease

1 reference

7 January 2021

The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma

1 reference

7 January 2021

Insulin-like growth factors and cancer

1 reference

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

7 January 2021

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1291

1 reference

25 August 2017

1 reference